ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,180.74
1.03%
US Tech 100
17,597.60
1.02%
다우존스 지수
38,852.27
0.46%
Bitcoin
63,333.25
-1.04%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Ocugen Inc (OCGN)

  7. Ocugen Inc (OCGN) 뉴스

OCGN Ocugen Inc

1.63
0.30 (22.56%)
시간외 거래
최종 업데이트: 05:15:16
15분 지연
기업명 주식 심볼 시장 주식 타입
Ocugen Inc OCGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.30 22.56% 1.63 05:15:16
개장가 저가 고가 종가 전일 종가
1.34 1.33 1.65 1.64 1.33
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202420:30GLOBEOcugen to Host Conference Call on Tuesday, May 14 at 8:30..
02/05/202420:15GLOBEOcugen Announces CSO to Present on Modifier Gene Therapy at..
29/04/202419:45GLOBEOcugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data..
26/04/202422:05GLOBEUPDATE -- Ocugen to Present on Modifier Gene Therapy..
26/04/202419:30GLOBEOcugen to Present on Modifier Gene Therapy Platform at..
19/04/202420:13GLOBEOcugen Announces Dosing Completion of Subjects with..
12/04/202420:30GLOBEOcugen to Participate in Fireside Chat at the Emerging..
10/04/202420:02GLOBEOcugen, Inc. Announces Positive Scientific Advice from the..
08/04/202419:30GLOBEOcugen, Inc. Announces U.S. FDA Clearance of IND Amendment..
05/04/202420:02GLOBEOcugen Announces Positive Data and Safety Monitoring Board..
02/04/202421:00GLOBEOcugen Provides Business Update with Certain Financials for..
02/04/202407:08GLOBEOcugen Announces Positive Data and Safety Monitoring Board..
02/04/202406:43GLOBEOcugen to Host Conference Call on Tuesday, April 2 at 8:30..
18/03/202419:30GLOBEOcugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical..
13/03/202421:00GLOBEOcugen, Inc. Announces Dosing Completion of Subjects with..
06/03/202421:30GLOBEOcugen to Present at Investing in Cures Summit
28/02/202422:00GLOBEOcugen Clinical Showcase Webcast Now Available
26/02/202422:30GLOBEOcugen Chairman and CEO to present at Abu Dhabi Family..
23/02/202406:05GLOBEOcugen, Inc. Announces Dosing Completion of Subjects with..
22/02/202406:05GLOBEOcugen to Present at 2024 BIO CEO & Investor Conference
22/02/202401:22EDGAR2Form 8-K - Current report
14/02/202421:30GLOBEOcugen to Host Clinical Showcase in New York City..
31/01/202422:00GLOBEOcugen to Present at Pharma Market Research Conference
16/01/202421:30GLOBEOcugen, Inc. Announces Bob Smith Joins Business Advisory..
08/01/202420:05EDGAR2Form 8-K - Current report
06/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202305:09EDGAR2Form 8-K - Current report
21/12/202320:30GLOBEOcugen Gains FDA Alignment on Key Aspects of OCU400—Modifier..
19/12/202321:30GLOBEOcugen Announces OCU400 Receives Regenerative Medicine..
13/12/202321:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
29/11/202321:30GLOBEOcugen CEO to Present at NobleCon19 – Noble Capital Markets’..
10/11/202321:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
09/11/202322:02EDGAR2Form 8-K - Current report
09/11/202321:02EDGAR2Form 8-K - Current report
09/11/202320:30GLOBEOcugen Provides Business Update with Third Quarter 2023..
09/11/202320:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:45GLOBEOcugen CSO to Participate in 4th Annual Dry AMD Therapeutic..
02/11/202320:30GLOBEOcugen to Host Conference Call on Thursday, November 9 at..
10/10/202322:05EDGAR2Form 8-K - Current report
10/10/202319:30GLOBEOcugen Mucosal Vaccine Candidate OCU500 Selected by..
04/10/202320:00GLOBEOcugen to Present at the 2023 Cell & Gene Meeting on the..
29/09/202320:30GLOBEOcugen CSO to Participate in 4th Annual Gene Therapy for..
28/09/202308:30GLOBEOcugen to Participate in Fireside Chat at Chardan’s 7th..
21/09/202320:30GLOBEOcugen, Inc. Announces Connie Collingsworth Joins Business..
20/09/202321:00GLOBEOcugen to Participate in Panel at Cantor Fitzgerald Global..
20/09/202305:54EDGAR2Form 8-K - Current report
20/09/202305:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
OCGN
Ocugen
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유